|
Part I General Aspects and Introductory Material |
|
|
1 | (264) |
|
1 Traditional Markers in Liver Disease |
|
|
3 | (20) |
|
|
|
2 Hepascore and Its Application to Liver Disease |
|
|
23 | (24) |
|
|
|
|
3 Model for End-Stage Liver Disease (MELD) Score as a Biomarker |
|
|
47 | (24) |
|
|
|
4 Mechanistic Biomarkers in Liver Diseases |
|
|
71 | (28) |
|
|
|
|
|
5 Liver Transplantation Biomarkers in the Metabolomics Era |
|
|
99 | (30) |
|
|
Juan Carlos Garcia-Cafiaveras |
|
|
|
|
6 Liver Biomarkers and Their Applications to Nutritional Interventions in Animal Studies |
|
|
129 | (24) |
|
Cynthia Aparecida de Castro |
|
|
Manoela Maciel dos Santos Dias |
|
|
|
Sandra Aparecida dos Reis |
|
|
Lisiane Lopes da Conceicao |
|
|
|
Luis Fernando de Sousa Moraes |
|
|
Maria do Carmo Gouveia Peluzio |
|
|
7 Serum Biomarkers for Evaluating Portal Hypertension |
|
|
153 | (14) |
|
|
|
|
8 Biomarkers for Recurrence of Hepatocellular Carcinoma |
|
|
167 | (26) |
|
|
|
|
9 Biomarkers to Monitor Graft Function Following Liver Transplantation |
|
|
193 | (28) |
|
|
|
|
|
10 Biomarkers of Extracellular Matrix Remodeling in Liver Diseases |
|
|
221 | (26) |
|
|
|
|
|
11 Interaction of Sialyl transferases. Sialidases, and Sialic Acids in Liver Diseases and Applications to Biomarker Discovery |
|
|
247 | (18) |
|
|
|
Part II Body Fluids, Tissue, and Specific Biomarkers |
|
|
265 | (372) |
|
12 Biomarkers in Focus: Alanine Aminotransferase |
|
|
267 | (14) |
|
|
13 Bilirubin as a Biomarker in Liver Disease |
|
|
281 | (24) |
|
|
|
|
|
14 AST-to-Platelet Ratio Index (APRI) as Marker in Liver Disease |
|
|
305 | (16) |
|
|
|
15 Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease |
|
|
321 | (28) |
|
|
|
|
Marlene Christina Nielsen |
|
|
|
|
|
|
16 CD133 and EpCAM as Biomarkers in Liver Diseases |
|
|
349 | (24) |
|
|
|
17 Graft-Derived Cell-Free DNA as a Biomarker in Liver Transplantation |
|
|
373 | (14) |
|
|
|
|
|
|
|
|
18 Cortisol as Biomarkers in Cirrhosis |
|
|
387 | (20) |
|
|
|
|
|
|
19 Serum Sialic Acid as a Biomarker in Liver Disease |
|
|
407 | (20) |
|
|
|
20 Osteopontin as a Biomarker in Liver Disease |
|
|
427 | (16) |
|
|
21 Type VI Collagen: Biological Functions and Its Neo-epitope as Hepatic Fibrosis Biomarker |
|
|
443 | (28) |
|
|
|
22 Hydroxyproline as a Biomarker in Liver Disease |
|
|
471 | (22) |
|
|
|
|
|
23 Fibrinogen a-Chain as a Serum Marker of Liver Disease |
|
|
493 | (20) |
|
|
|
24 YKL-40 as a Biomarker of Liver Diseases |
|
|
513 | (14) |
|
|
25 Phosphatidylethanol and Alcohol Use in Liver Disease Patients |
|
|
527 | (18) |
|
|
26 Circulating Extracellular Vesicles as Liver Biomarkers |
|
|
545 | (14) |
|
|
27 Squamous Cell Carcinoma Antigen-Immunoglobulin M (SCCA-IgM) as Biomarker in Liver Disease: Biological Aspects and Clinical Applications |
|
|
559 | (22) |
|
|
|
|
|
|
28 Peripheral Venous, Portal Venous, Hepatic Venous, and Arterial and Intrahepatic Cytokine Levels as Biomarkers and Functional Correlations |
|
|
581 | (22) |
|
|
|
|
29 Pentraxin 3 (PTX3) as a Biomarker of Liver Disease |
|
|
603 | (20) |
|
|
|
30 Alpha-Fetoprotein as a Biomarker in Hepatocellular Carcinoma: Focus on Its Role in Composition of Tumor Staging Systems and Monitoring of Treatment Response |
|
|
623 | (14) |
|
|
|
|
Part III Genetic, Histological, Physical, and Imaging Methods |
|
|
637 | (116) |
|
31 Genetic Biomarkers of Paracetamol (Acetaminophen)-Induced Acute Liver Failure |
|
|
639 | (28) |
|
|
32 PNPLA3 Polymorphism and Nonalcoholic Fatty Liver Disease |
|
|
667 | (26) |
|
|
|
|
33 Histological Biomarkers of Nonalcoholic Fatty Liver Disease |
|
|
693 | (14) |
|
|
|
34 Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression in Liver Disease |
|
|
707 | (12) |
|
|
|
35 Immunohistochemistry for Viral Hepatitis: Methods and Applications |
|
|
719 | (16) |
|
|
36 Phase Angle Bioelectrical Impedance Analysis (BIA) as a Biomarker Tool for Liver Disease |
|
|
735 | (18) |
|
|
|
|
|
Part IV Specific Diseases and Conditions |
|
|
753 | (244) |
|
37 Biomarkers Associated with Adiposity and Metabolic Dysfunction in Hepatobiliary Tract Cancer |
|
|
755 | (30) |
|
|
|
|
38 Biomarkers of the Antioxidant Response: A Focus on Liver Carcinogenesis |
|
|
785 | (24) |
|
Ricardo Sanchez-Rodriguez |
|
|
Julia Esperanza Torres-Mena |
|
|
|
Julio Isael Perez-Carreon |
|
|
39 microRNA-155 and microRNA-196b in Hepatitis C Virus Infection |
|
|
809 | (28) |
|
|
40 Serum Alpha-Fetoprotein as a Biomarker in Liver Transplantation |
|
|
837 | (34) |
|
|
|
|
41 Immunological Biomarkers in Liver Transplantation |
|
|
871 | (30) |
|
|
|
|
|
|
42 Biomarkers for Hepatocellular Carcinoma in East Asia |
|
|
901 | (26) |
|
|
|
|
43 Monocyte Chemotactic Protein-1 (Cytokine, Receptors, and Gene Polymorphisms) in Hepatitis |
|
|
927 | (30) |
|
|
|
44 Hepatic Biomarkers in Diabetes as Modulated by Dietary Phytochemicals |
|
|
957 | (20) |
|
|
|
|
45 Inflammatory Biomarkers in Ascites |
|
|
977 | (20) |
|
|
|
|
|
997 | (10) |
|
46 Recommended Resources on Biomarkers of Liver Diseases |
|
|
999 | (8) |
|
|
|
Index |
|
1007 | |